November 11, 2025 — Leads & Copy — Cibus, Inc. (Nasdaq: CBUS) has elected Craig Wichner to its Board of Directors. Wichner will also serve on the Strategy Committee.
Mark Finn, Chairman of the Board of Cibus, said Wichner brings financial acumen, strategic discipline, and industry insight. Finn added that Wichner’s expertise in sustainable growth and capital strategy in agriculture will help strengthen the company’s position as Cibus prepares for commercial scaling of its trait platform.
Wichner is the Founder and Managing Partner of Farmland LP, a U.S. farmland investment management firm with more than $350 million in assets and over 19,000 acres under management. Since founding the firm in 2009, Wichner has been a leader in regenerative and organic farming practices that drive financial performance and environmental outcomes. His background includes technology, real estate investment, and agribusiness development.
Wichner said he is honored to join the Cibus Board during agricultural innovation. He noted that Cibus’ platform can accelerate the development of gene-edited traits and deploy them through licensing partnerships with leading seed companies, expanding the company’s reach and enabling farmers to produce more with fewer inputs through sustainable crop innovation.
Before Farmland LP, Wichner founded and managed technology and investment companies focused on data-driven business models and sustainable growth. He also served on the Board of Directors of BN Ranch, the successor to Niman Ranch, acquired by Blue Apron Holdings, Inc. Wichner holds a Bachelor of Science in Biochemistry and Molecular Biology, with a minor in Economics, from the University of California, San Diego.
Cibus develops traits that address productivity, yield, and sustainability challenges. Its high-throughput gene-editing technologies focus on productivity traits for farmers of major global row crops. Cibus licenses its traits to customers in exchange for royalties, using its gene editing technologies to develop plant traits quickly and cost-effectively.
Jeff Sonnek – ICR, jeff.sonnek@icrinc.com
Colin Sanford – Bioscribe, colin@bioscribe.com
Source: Cibus, Inc.
